Literature DB >> 10754952

Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia.

F J Bowden1, B A Paterson, J Mein, J Savage, C K Fairley, S M Garland, S N Tabrizi.   

Abstract

OBJECTIVE: To estimate more accurately the age specific prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection (HPV) in indigenous women living in urban, rural, and remote areas of the "Top End" of the Northern Territory (NT).
DESIGN: Analysis of data obtained from two community based studies using self administered tampon specimens tested by polymerase chain reaction for sexually transmitted disease (STD). Data pertaining to the notifiable STDs (N gonorrhoeae and C trachomatis) were obtained from the NT health department. PATIENTS: 1090 indigenous women (age range 12-73 years) were enrolled when they attended local community health centres, family planning clinics, and STD clinics. The majority attended clinics in their home community in the course of "well women's checks" which encourage women to undergo screening for a variety of general medical conditions.
RESULTS: The overall prevalence of T vaginalis, C trachomatis, N gonorrhoeae, and HPV was 0.25 (95% CI: 0.22-0.28), 0.11 (0.09-0.13), 0.17 (0.15-0.19), and 0.42 (0.37-0.48) respectively. Of the women found to be infected (excluding HPV), 25.5% had two or more of the above organisms detected. There was a statistically significant increase in the age specific prevalence of T vaginalis but a significant decrease with age for C trachomatis and HPV infection. There was no statistically significant change for N gonorrhoeae with age.
CONCLUSIONS: STDs are hyperendemic in this population of indigenous women and the notification data significantly underestimate their prevalence. Distinct patterns of age specific prevalence were demonstrated, highlighting the need to tailor control strategies to specific epidemiological features.

Entities:  

Mesh:

Year:  1999        PMID: 10754952      PMCID: PMC1758254     

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  17 in total

1.  Epidemiological studies on human trichomoniasis.

Authors:  T A BURCH; C W REES; L V REARDON
Journal:  Am J Trop Med Hyg       Date:  1959-05       Impact factor: 2.345

2.  A self-administered technique for the detection of sexually transmitted diseases in remote communities.

Authors:  S N Tabrizi; B Paterson; C K Fairley; F J Bowden; S M Garland
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Sexually transmitted diseases in disadvantaged Australian communities.

Authors:  C K Fairley; F J Bowden; N J Gay; B A Paterson; S M Garland; S N Tabrizi
Journal:  JAMA       Date:  1997-07-09       Impact factor: 56.272

4.  Self-administered vaginal swabs for population-based assessment of Trichomonas vaginalis prevalence.

Authors:  M J Wawer; D McNairn; F Wabwire-Mangen; L Paxton; R H Gray; N Kiwanuka
Journal:  Lancet       Date:  1995-01-14       Impact factor: 79.321

5.  An evaluation of trichomoniasis in two ethnic groups in Papua New Guinea.

Authors:  V Zigas
Journal:  Sex Transm Dis       Date:  1977 Apr-Jun       Impact factor: 2.830

6.  HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk.

Authors:  E Klouman; E J Masenga; K I Klepp; N E Sam; W Nkya; C Nkya
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-02-01

7.  The contribution of community health surveys to aboriginal health in the 1990s.

Authors:  D B Mak; R McDermott; A J Plant; D Scrimgeour
Journal:  Aust N Z J Public Health       Date:  1998-10       Impact factor: 2.939

8.  Community based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: prevalence and risk factors.

Authors:  M Passey; C S Mgone; S Lupiwa; N Suve; S Tiwara; T Lupiwa; A Clegg; M P Alpers
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

9.  The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women.

Authors:  B A Paterson; S N Tabrizi; S M Garland; C K Fairley; F J Bowden
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

10.  Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.

Authors:  S N Tabrizi; B A Paterson; C K Fairley; F J Bowden; S M Garland
Journal:  Int J STD AIDS       Date:  1998-06       Impact factor: 1.359

View more
  15 in total

1.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

2.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.

Authors:  F J Bowden; G P Garnett
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

Review 3.  Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Authors:  Kawthar Bouchemal; Christian Bories; Philippe M Loiseau
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Chlamydia trachomatis infections in Greece: first prevalence study using nucleic acid amplification tests.

Authors:  S Levidiotou; G Vrioni; H Papadogeorgaki; K Avdeliodi; H Kada; G Kaparos; E Kouskouni; E Fragouli; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

5.  Genetic typing of the porin protein of Neisseria gonorrhoeae from clinical noncultured samples for strain characterization and identification of mixed gonococcal infections.

Authors:  Freyja Lynn; Marcia M Hobbs; Jonathan M Zenilman; Frieda M T F Behets; Kathleen Van Damme; Andry Rasamindrakotroka; Margaret C Bash
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.

Authors:  A L Cunningham; R Taylor; J Taylor; C Marks; J Shaw; A Mindel
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

7.  Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia.

Authors:  H Williams; S N Tabrizi; W Lee; G T Kovacs; S Garland
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

8.  Factors affecting the detection rate of human papillomavirus.

Authors:  Diane M Harper; Meghan R Longacre; Walter W Noll; Dorothy R Belloni; Bernard F Cole
Journal:  Ann Fam Med       Date:  2003 Nov-Dec       Impact factor: 5.166

9.  Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function.

Authors:  Bibhuti N Singh; Gary R Hayes; John J Lucas; Ulf Sommer; Nelly Viseux; Ekaterina Mirgorodskaya; Radiana T Trifonova; Rosaria Rita S Sassi; Catherine E Costello; Raina N Fichorova
Journal:  Glycoconj J       Date:  2008-07-06       Impact factor: 2.916

10.  Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities.

Authors:  Matthew P Stevens; Sepehr N Tabrizi; Rosanne Muller; Vicki Krause; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.